EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis

Effekte einer Zimt-Supplementierung auf metabolische Biomarker bei Personen mit Typ-2-Diabetes: systematische Übersicht und Metaanalyse

Suzana Laís de Moura iD, Bruna Gabrielle Rocha Gomes iD, Mariana Julião Guilarducci iD, Olívia Gonçalves Leão Coelho iD, Nathalia Sernizon Guimarães iD, Júnia Maria Geraldo Gomes iD

Nutrition Reviews · 01.02.2025 · 83 (2) · 249-279

DOI: 10.1093/nutrit/nuae058 ↗

Auf einen Blick

28 RCTs mit 3054 Patient:innen mit DM2 zeigen: Zimt war mit niedrigeren Glukosewerten, HbA1c und HOMA-IR verbunden. Bei Kapseln und ≤2 g/Tag zeigten sich zusätzliche Effekte.

Fragestellung

Welchen Effekt hat eine Zimt-Supplementierung auf metabolische Biomarker bei Erwachsenen und Älteren mit DM2?

Methode

Systematische Übersicht und Metaanalyse von RCTs; Suche in PubMed/MEDLINE, Cochrane CENTRAL und Embase bis 10. November 2022; Random-effects-Modelle, JBI, GRADE.

Ergebnisse

28 RCTs, 30 bis 120 Tage, 3054 Patient:innen. Zimt senkte FBG, postprandiale Glukose, HbA1c und HOMA-IR; Kapseln zusätzlich Gesamtcholesterin, LDL-C und Triglyzeride.

Einschränkungen

Hohe Heterogenität bei mehreren Endpunkten (I2 bis 100 %).

Schlussfolgerung der Autor:innen

Die Daten deuten darauf hin, dass Zimt das glykämische und lipidbezogene Profil sowie den BMI verbessert, besonders als Kapsel und bei ≤2 g/Tag.

Kernaussagen

  • FBG, postprandiale Glukose, HbA1c und HOMA-IR waren reduziert
  • Kapseln zeigten zusätzliche Effekte auf Lipidwerte
  • Bei ≤2 g/Tag wurden auch BMI, HbA1c und HOMA-IR reduziert

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrition Reviews, online erschienen am 25.06.2024. Verfasst von Suzana Laís de Moura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Federal Institute of Education, Science and Technology of the Southeast of Minas Gerais-Campus Barbacena-IF Sudeste MG, Barbacena, MG, 36.205-018, Br…. Hauptthemen laut MEDLINE: Biomarkers, Cinnamomum zeylanicum, Diabetes Mellitus, Type 2, Dietary Supplements. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 66 Literaturangaben.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The global prevalence of type 2 diabetes mellitus (DM2) has been rising significantly over the years. Recent studies have shown beneficial effects of cinnamon on metabolic biomarkers.

Objective

The objective of this review was to assess the effect of cinnamon supplementation on metabolic biomarkers in patients with DM2. Data Sources The Pubmed/MEDLINE, Cochrane CENTRAL, and Embase databases were searched up to November 10, 2022. Data Extraction A systematic search was performed for randomized controlled trials (RCTs) evaluating the effect of cinnamon supplementation on metabolic biomarkers, in adults and the elderly with DM2, and comparing the data for a cinnamon intervention group with that for a placebo group or a control group. The main exclusion criteria were studies (1) with other types of diabetes (ie, gestational diabetes or type 1 diabetes), (2) without cinnamon consumption, (3) that did not evaluate metabolic biomarkers, or (4) in vitro and animal studies. Two researchers independently screened 924 records, evaluated full-text studies, extracted data, and appraised their quality. A third researcher was consulted to resolve any discrepancies. The data were pooled using random-effects models and expressed as the weighted mean difference (WMD) with 95% CI. Heterogeneity was assessed using Cochran’s Q test and quantified using I2 statistics. Risk of bias was assessed using the Joanna Briggs Institute (JBI) instrument. Sensitivity analysis and the GRADE system were used to assess the robustness and certainty of the findings. Data Analysis In total, 28 RCTs with a duration ranging from 30 to 120 days and a total enrollment of 3054 patients with DM2 were included. Participants consuming cinnamon showed a significant reduction in fasting blood glucose (FBG) (WMD: −15.26 mg/dL; 95% CI: −22.23 to −8.30; I2 = 88%), postprandial glucose (WMD: −39.22 mg/dL; 95% CI: −63.90 to −14.55; I2 = 100%), HbA1c (WMD: −0.56 mg/dL; 95% CI: −0.99 to −0.13; I2 = 94%), and HOMA-IR (WMD = −0.76, 95% CI: −1.13 to −0.39; I2 = 22%) compared with the control group. An intervention of cinnamon in capsule form reduced FBG (WMD:−18.43 mg/dL, 95% CI: −26.32 to −10.53; I2 = 89%), postprandial glucose (WMD: −44.83 mg/dL, 95% CI: −70.67 to −18.99; I2 = 100%), HbA1c (WMD: −0.56 mg/dL, 95% CI: −1.02 to −0.09; I2 = 94%), total cholesterol (WMD: −13.39 mg/dL; 95% CI: −24.71 to −2.07; I2 = 96%), LDL-C (WMD: −6.49 mg/dL, 95% CI: −12.69 to −0.29; I2 = 92%), and triglycerides (WND: −19.75 mg/dL; 95% CI, −33.71 to −5.80; I2 = 88%). Both doses (≤2 g/day and >2 g/day) reduced FBG and postprandial glucose. Only cinnamon doses of ≤2 g/day reduced HbA1c (WMD: −0.68 mg/dL, 95% CI: −1.16 to −0.1; I2 = 92%), HOMA-IR (WMD: −0.94 mg/dL; 95% CI: −1.21 to −0.67; I2 = 0%), and BMI (WMD: −1.18 kg/m2; 95% CI: −1.97 to −0.39; I2 = 0%).

Conclusion

The data suggest that cinnamon improves the glycemic and lipid profile and reduces the BMI, particularly in DM2 patients who receive cinnamon supplementation in capsule form and at a dose of ≤2 g/day. Systematic Review Registration PROSPERO registration no. CRD42022370332.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersCinnamomum zeylanicumDiabetes Mellitus, Type 2Dietary SupplementsHumansBlood GlucoseGlycated HemoglobinRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

cinnamonmetabolic biomarkersrandomized controlled clinical trials (RCTs)type 2 diabetes mellitus

Substanzen

BiomarkersBlood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • Federal Institute of Education, Science and Technology of the Southeast of Minas Gerais-Campus Barbacena-IF Sudeste MG, Barbacena, MG, 36.205-018, Brazil.
  • School of Public Health, University of São Paulo-FSP/USP, São Paulo, SP, 01.246-904, Brazil.
  • Federal University of Viçosa-Campus Viçosa-UFV, Viçosa, MG, 36.570-900, Brazil.
  • Department of Nutrition, Federal University of Minas Gerais School of Nursing, Belo Horizonte, MG, 30.130-100, Brazil.

ORCID-Profile: Suzana Laís de Moura, Bruna Gabrielle Rocha Gomes, Mariana Julião Guilarducci, Olívia Gonçalves Leão Coelho, Nathalia Sernizon Guimarães, Júnia Maria Geraldo Gomes

Zitieren

APA

de Moura, S. L., Gomes, B. G. R., Guilarducci, M. J., Coelho, O. G. L., Guimarães, N. S., & Gomes, J. M. G. (2025). Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis. Nutrition Reviews, 83(2), 249-279. https://doi.org/10.1093/nutrit/nuae058

Vancouver

de Moura SL, Gomes BGR, Guilarducci MJ, Coelho OGL, Guimarães NS, Gomes JMG. Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis. Nutrition Reviews. 2025;83(2):249-279. doi:10.1093/nutrit/nuae058

BibTeX
@article{deMoura2025,
  author = {de Moura, Suzana Laís and Gomes, Bruna Gabrielle Rocha and Guilarducci, Mariana Julião and Coelho, Olívia Gonçalves Leão and Guimarães, Nathalia Sernizon and Gomes, Júnia Maria Geraldo},
  title = {Effects of cinnamon supplementation on metabolic biomarkers in individuals with type 2 diabetes: a systematic review and meta-analysis},
  journal = {Nutrition Reviews},
  year = {2025},
  volume = {83},
  number = {2},
  pages = {249--279},
  doi = {10.1093/nutrit/nuae058}
}
Kostenlos starten →